Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRLD - Prelude Therapeutics: Interesting Pipeline That Is Too Early To Warrant My Buy
February, 05 2024 05:07 AM
Prelude Therapeutics Incorporated
2024-02-05 05:07:24 ET
Summary Prelude Therapeutics is a clinical-stage biopharma developing targeted therapies for different cancers. PRLD has three drugs in clinical testing, including a degrader of a protein involved in cell division and a CDK9 inhibitor. The company has a strong cash position but may not have enough funding to reach important data readouts, making it a "hold and watch" investment.
Topline Summary For further details see:
Prelude Therapeutics: Interesting Pipeline That Is Too Early To Warrant My Buy
Stock Information
Company Name:
Prelude Therapeutics Incorporated
Stock Symbol:
PRLD
Market:
NASDAQ
Website:
preludetx.com
Get PRLD Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .